已发表的部分文献: 标题:Silencing of integrated human papillomavirus-16 oncogenes by small interfering RNA-mediated heterochromatization.作者:Palanichamy JK, Mehndiratta M, Bhagat M, Ramalingam P, Das B, Das P, Sinha S, Chattopadhyay P;杂志名称:Mol Cancer Ther 标题:Translocation of forkhead box O1 to the nuclear periphery induces histone modifications that regulate transcriptional repression of PCK1 in HepG2 cells.作者:Arai T, Kano F, Murata M;杂志名称:Genes Cells 标题:Aberrant Epigenetic Alterations of Glutathione-S-Transferase P1 in Age-Related Nuclear Cataract.作者:Chen J, Zhou J, Wu J, Zhang G, Kang L, Ben J, Wang Y, Qin B, Guan H;杂志名称:Curr Eye Res Epigentek 公司是全球领先的表观遗传学相关研究的技术创新者和产品开发供应商。开发了超过700多个专利产品,为表观遗传学方面的研究和新药研发提供全面系统的解决方案,涵盖样品制备、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、组蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等领域,提供小分子抑制剂、蛋白质、抗体、以及分析试剂盒产品。